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Abstract 
Background: MicroRNA-720 (miR-720), a nonclassical miRNA, is involved in the initiation and progression of several 
tumors. In our previous studies, miR-720 was shown to be significantly upregulated in cervical cancer tissues com-
pared with normal cervical tissues. However, the precise biological functions of miR-720, and its molecular mecha-
nisms of action, are still unknown.
Results: Microarray expression profiles, luciferase reporter assays, and western blot assays were used to validate 
Rab35 as a target gene of miR-720 in HEK293T and HeLa cells. The regulation of Rab35 expression by miR-720 was 
assessed using qRT-PCR and western blot assays, and the effects of exogenous miR-720 and Rab35 on cell migration 
were evaluated in vitro using Transwell® assay, wound healing assay, and real-time analyses in HeLa cells. The influ-
ences of exogenous miR-720 on cell proliferation were evaluated in vitro by the MTT assay in HeLa cells. In addition, 
expression of E-cadherin and vimentin associated with epithelial-mesenchymal transition were also assessed using 
western blot analyses after transfection of miR-720 mimics and Rab35 expression vectors. The results showed that 
the small GTPase, Rab35, is a direct functional target of miR-720 in cervical cancer HeLa cells. By targeting Rab35, 
overexpression of miR-720 resulted in a decrease in E-cadherin expression and an increase in vimentin expression and 
finally led to promotion of HeLa cell migration. Furthermore, reintroduction of Rab35 3′-UTR(−) markedly reversed the 
induction of cell migration in miR-720-expressing HeLa cells.
Conclusions: The miR-720 promotes cell migration of HeLa cells by downregulating Rab35. The results show that 
miR-720 is a novel cell migration-associated gene in cervical cancer cells.
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Background
Discovered in 1993, microRNAs (miRNAs) are a class 
of short, non-coding RNAs that are highly efficient gene 
expression regulators in various cellular processes [1–5]. 
They modulate gene expression predominantly through 
an interaction with the 3′-UTR of their target mRNAs 
[6, 7]. Increasing evidence suggests that dysfunctions 
of miRNAs are involved in the initiation and progres-
sion of cancer [8, 9], as well as in animal developmental 
processes [10]. It has been reported that miR-720 is not a 
classic miRNA, but is probably a fragment of tRNA [11]. 
Hara et al. identified miR-720 as a novel miRNA regula-
tor in the differentiation of dental pulp cells [12]. Other 
studies suggested that circulating miR-720 was a novel 
serum biomarker in some tumors, such as colorectal 
cancers [13] and myelomas [14]. Furthermore, miR-720 
could act as a colorectal cancer-promoting factor, and 
could be a marker for the prognosis of colorectal cancer 
[15]. Previous results have reported that miR-720 is also 
frequently decreased in breast cancer and functions as an 
anti-metastatic gene by downregulating TWIST1 [16]. 
Our previous studies suggested that miR-720 expression 
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is significantly upregulated in cervix uteri squamous cell 
carcinoma tissues, when compared with normal cervix 
uteri tissues [17]. Cervical cancer is the third most com-
monly diagnosed cancer, and the fourth most common 
type of cancer among women, worldwide [18]. However, 
the roles of miR-720 in the initiation and progression of 
cervical cancer are still largely unknown.
The small GTPase, Rab35, is a member of the RAS onco-
gene family. It regulates many essential cellular processes, 
such as recycling from endosomes for neurite outgrowth 
[19–25], exosome release [26], cytokinesis [27], and actin 
cytoskeleton organization [28–31] by cycling between a 
GTP-bound active form and a GDP-bound inactive form 
[32]. In addition, Rab35 is involved in the early stage of 
FcγR-mediated phagocytosis in macrophages [33] and also 
acts as a regulator of vesicle transport required specifically 
for phagocytosis [34]. Although Rab35 has been shown to 
regulate various cellular processes, its precise roles in these 
processes are not fully understood. Moreover, several 
recent studies have reported that dysfunctions of Rab35 
also exert vital functions, such as regulation of myoblast 
fusion and cadherin-dependent adherens junction for-
mation [35]. Some studies showed that Wnt5a promotes 
breast cancer cell migration via the Dvl2/Rab35/Rac1 sign-
aling pathway [36], and Rab35 maintains cadherins at the 
cell surface to promote cell–cell adhesion [37].
In the present study, we therefore sought to deter-
mine the role of miR-720 in cervical cancer cells. We 
first defined miR-720 as a new, in  vitro cell migration-
associated miRNA in HeLa cells. And overexpression or 
inhibition of miR-720 did not significantly affect HeLa 
cell proliferation. Moreover, we identified Rab35, a key 
regulator of endosomal membrane trafficking, as a direct 
and functional target of miR-720. The newly identified 
miR-720/Rab35 axis provides a molecular mechanism 
for abnormal cell migration in cervical cancer cells via its 
effects on the expression of an epithelial marker, E-cad-
herin, and a mesenchymal marker, vimentin.
Results
miR‑720 promotes cell migration but does not affect cell 
proliferation in HeLa cells
In our previous study, we found the expression level of 
miR-720 was significantly upregulated in cervical can-
cer tissues compared to normal adjacent tissues [17]. 
To further explore its functions in the development and 
progression of cervical cancer, we assessed the influence 
of miR-720 on cell migration and cell proliferation in 
HeLa cells, by gain- and loss-of-function analyses. First, 
we showed that miR-720 mimics could lead to a signifi-
cant increase in miR-720 expression (Fig. 1a). Then, cell 
migration assays were performed after HeLa cells were 
Fig. 1 MiR-720 promotes cell migration but does not affect cell pro-
liferation in HeLa cells. a The qRT-PCR analysis of miR-720 expression 
indicated that HeLa cells transfected with miR-720 mimics (M-720) 
showed a significant increase in miR-720 expression compared with 
cells transfected with the microRNA mimic negative control (M-NC). 
b Representative photographs of wound healing assays (100×) show 
that HeLa cells transfected with miR-720 mimics result in a signifi-
cant improvement in wound healing ability. The statistical results of 
cell migration area measured by Image J software demonstrate a 
significant difference in cell migration ability caused by overexpres-
sion of miR-720. **p < 0.01. c Transwell® migration assay shows that 
the upregulation of miR-720 dramatically enhances cell migration 
ability. The top panel shows representative photographs of the 
Transwell® migration assay and the bottom panel shows the statistical 
results. **p < 0.01. d Twenty-four hours after transfection, real-time 
cell analysis (RTCA) experiments were performed to contrast cell 
migration indices between cells transfected with miR-720 mimics 
and the microRNA mimic negative control. The results show that after 
8 h, the migration indices of cells transfected with miR-720 mimics 
were greater than the controls. e The results of qRT-PCR analysis of 
miR-720 expression show that the miR-720 inhibitors can effectively 
knockdown miR-720 in HeLa cells. **p < 0.01. The (3-4,5-dimethyl-
2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) assays show 
upregulation (f) or downregulation (g) of miR-720, does not show an 
effect on cell proliferation viability in HeLa cells
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transfected for 24 h with the miR-720 mimic (M-720) or 
the miR-mimic negative control (M-NC). Overexpres-
sion of miR-720 in HeLa cells significantly promoted 
migration ability, as determined by wound healing 
assays, showing that the abilities of migrated cells filling 
a scratch was significantly enhanced in miR-720-overex-
pressed cells than the M-NC cells (p < 0.01) (Fig. 1b). The 
induction effect of miR-720 on cell migration was further 
confirmed by Transwell® assays. The representative pho-
tographs of Transwell® migration, plus the histogram of 
the results, both showed that the M-720 had a significant 
improvement on cell migration (Fig. 1c). A real-time cell 
analysis is a new method to accurately detect cell migra-
tion in real time. Using this method, we further demon-
strated that upregulation of miR-720 could induce cell 
migration in HeLa cells (Fig. 1d).
In addition, inhibition by miR-720 inhibitors resulted 
in a dramatic decrease in miR-720 expression (Fig.  1e). 
We therefore used these transfected cells to conduct 
3-4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazo-
lium bromide (MTT) assays to assess the effects of miR-
720 on cell proliferation. The results showed that neither 
the miR-720 mimic nor the miR-720 inhibitor had signifi-
cant effects on cell proliferation (Fig. 1f, g). Thus, we next 
studied the role of miR-720 in cell migration of HeLa 
cells.
Identification of the miR‑720 targets by integrative 
bioinformatics analysis
In order to characterize the molecular mechanism of 
miR-720 on cell migration, the potential mRNA targets of 
miR-720 were identified. To investigate the potential target 
genes and their binding sites on the seed region of miR-
720, we used the TargetScan program (http://www.tar-
getscan.org/) [7, 38, 39] and the miRanda program (http://
www.microrna.org/) [40]. The TargetScan and miRanda 
program predicted respectively 827 and 1328 candidate 
genes, which were possible targets of miR-720 (Fig. 2b).
Recent studies have shown that miRNAs can reduce 
the levels of many of their target transcripts, and not just 
protein expression deriving from these transcripts [41]. 
Based on these observations, we used a high throughout 
genome mRNA microarray to identify potential target 
genes of miR-720. We performed global microarray gene 
expression profiling using the Human Genome U133 
Plus 2.0 Array (Affymetrix, Santa Clara, CA, USA) in 
HEK293T cells transfected with pre-miR-720 or negative 
control mimics. Twenty-four hours after transfection, the 
expression level of miR-720 (relative to endogenous U6 
RNA) in HEK293T cells was determined by qRT-PCR. 
The expression level of miR-720 was increased about 
550-fold as compared to the negative control. The micro-
array results showed that when compared with the con-
trols, 216 probes, representing 195 genes (three of these 
genes are still unnamed and not included) were downreg-
ulated by ≥2-fold (p < 0.05) in pre-miR-720 transfected 
HEK293T cells (Fig. 2a; Additional file 1: Table S1). Using 
a Gene List Venn Diagram, we identified 10 potential tar-
get genes as CHP, INSIG1, INTS7, KCTD15, METTL2B, 
NRXN3, PER2, RAB35, SGK3, and TET2 among the 
microarray results and the putative miR-720 target gene 
list (as predicted by TargetScan and miRanda) (Fig. 2c).
Fig. 2 Identification of miR-720 targets. a Microarray assays were performed on HEK293T cells transfected with pre-miR-720 and the pre-miR-con-
trol. The red dots represent genes upregulated with a ≥2-fold change, the green dots represent genes downregulated with a >0.5-fold change, and 
the gray dots indicate genes with expression levels ranging from −0.5-fold change to +2-fold change in the scatterplot. b The Venn diagram shows 
the relationships between the mRNA microarray and two miRNA-target prediction algorithms on the quantity of miR-720 targets. The TargetScan 
program and the miRanda program predicted that 827 candidate genes and 1328 candidate genes, respectively, were possible targets of miR-720. 
Expressions of 192 genes in HEK293T cells were changed ≥2-fold with a p value cut-off of 0.05 by ectopic expression of pre-miR-720. Among these 
192 genes, 14 and 20 were predicted by TargetScan 5.1 and miRanda, respectively. Among these 20 genes, 10 were classified as the intersection 
targets. c The heat map shows the change in expression levels of 10 genes with overexpression of miR-720
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Identification of miR‑720 targets by the luciferase reporter 
assay
Using luciferase reporter assays, we next sought to verify 
direct regulation of these candidate targets by miR-720. 
Among these candidate target genes, except for KCTD15 
with two predicted miR-720 binding sites in 3′-UTR, the 
rest of the target genes had only a predicted target site 
in 3′-UTR. We subcloned the partial 3′-UTRs contain-
ing the miR-720-binding sites of these candidate target 
genes, such as Rab35, into the luciferase-based reporter 
vector pMIR-REPORT (Ambion, Austin, Texas, US), 
and cotransfected the reporter constructs in HEK293T 
cells with the pre-miR-720 precursor or negative control 
(Fig. 3a). Among these reporter constructs, miR-720 sig-
nificantly suppressed the luciferase activity of the reporter 
vector containing binding sites in INSIG1, KCTD15, 
METTL2B, NRXN3, Rab35, RASAL2, or TET2, but not in 
CHP, PER2, or SGK3 for miR-720 targeting (Fig. 3b). To 
further confirm the predicted miRNA binding sites, seven 
base pair mutations of the miR-720 binding sites on the 
INSIG1, KCTD15, METTL2B, NRXN3, Rab35, RASAL2, 
and TET2 genes were generated by site-directed mutagen-
esis. Because KCTD15 has two predicted binding sites in 
its 3′-UTR, we performed molecular cloning for single 
site mutations to obtain vectors named MUT1-KCTD15, 
MUT2-KCTD15, and double site mutation vectors named 
MUT1,2-KCTD15. As expected, once the miR-720 bind-
ing sites in the 3′-UTR of these candidate target mRNAs 
were mutated, the luciferase activities could not be sup-
pressed by miR-720 (Fig. 3c). Taken together, the results of 
these reporter assays showed that miR-720 could directly 
bind to the 3′-UTR of INSIG1, KCTD15, and RAB35.
Rab35 is a target of miR‑720 in HeLa cells
The studies suggested that INSIG1 is an insulin-induced 
gene and encodes an endoplasmic reticulum (ER) mem-
brane protein that plays a critical role in regulating cho-
lesterol concentrations in cells [42–46]; and Kctd15 has 
a role in regulating the neural crest formation in the 
embryo [47, 48]. And Rab35 was involved in breast can-
cer cell migration processes [36] and promotes cell–cell 
adhesion [37]. Because miR-720 could induce cell migra-
tion in HeLa cells, we focus our initial research empha-
sis on Rab35. Firstly we further confirmed whether the 
mRNA and protein expression levels of Rab35 could 
have been regulated by miR-720 in cervical cancer HeLa 
cells. The results showed that mRNA expression of Rab35 
was not significantly affected by both the overexpression 
and suppressed expression of miR-720 (Fig. 4a, b). How-
ever, the protein level of Rab35 was negatively regulated 
by miR-720 in HeLa cells as expected (Fig. 4c). Thus, we 
propose that miR-720 plays a role in the regulation of 
Rab35 at the translational level in HeLa cells.
Rab35 can suppress cell migration of HeLa cells
Then we wondered whether Rab35 had negative effects 
on cell migration in HeLa cells compared with miR-720. 
So we constructed a miR-720 insensitive Rab35 expres-
sion vector (pcDNA3.0-Rab35) that only included 
the coding sequence of Rab35 on the base of the 
Fig. 3 Dual luciferase reporter assays verify that miR-720 regulates 
its targets by binding directly to their 3′-UTR. a The diagram shows 
that 3′-UTR of Rab35 was cloned downstream into the open reading 
frame of the pcDNA3.0-Vector, and also displays the detailed binding 
sites or the mutated binding sites of the 3′-UTR for miR-720 targeting; 
b The results of analysis indicate that the relative luciferase activities 
of the pMIR-REPORT vector containing wide-type 3′-UTR of INSIG1, 
KCTD15, METTL2B, NRXN3, Rab35, RASAL2, or TET2 could be decreased 
by upregulating miR-720; Firefly luciferase activity was normalized 
to Renilla luciferase activity. The relative luciferase expression level is 
expressed as the mean ± standard deviation (SD). Three independent 
experiments were performed, and representative data are shown. 
*p < 0.05 shows the significant difference. c Normalized luciferase 
activity in cells transfected with reporter vector containing mutant 
type 3′-UTR of KCTD15, INSIG1, or RAB35 could not be affected by 
overexpression of miR-720 compared with cells transfected with wild 
type 3′-UTR. The relative luciferase expression level is expressed as 
the mean ± standard deviation (SD). Three independent experiments 
were performed, and representative data are shown. *p < 0.05 shows 
the significant difference
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pcDNA3.0-Vector, to escape miR-720 targeting. The 
overexpression level of this vector was assessed by west-
ern blotting, and the results showed that the vector suc-
cessfully induced Rab35 overexpression (Fig.  5a). Then, 
we assayed the impact of forced expression of Rab35 on 
cell migration of HeLa cells. Using the wound healing 
assay, the overexpression of Rab35 inhibited the healing 
of the scratch when compared to the control group trans-
fected with the empty pcDNA3.0-Vector (Fig.  5b). In 
the other two types of cell migration assays (Transwell® 
migration assay and real-time cell analysis), we con-
sistently found that Rab35 had the ability to inhibit cell 
migration of HeLa cells (Fig. 5c, d). These results showed 
that Rab35 has an opposite effect on HeLa cell migration, 
in comparison with miR-720, indicating that it may be a 
functional target of miR-720 in HeLa cells.
miR‑720 mediates cell migration by targeting Rab35 
in HeLa cells
In the previous experiments, overexpression of miR-720 
could promote cell migration of HeLa, and forced expres-
sion of Rab35 could suppress cell migration. To further 
demonstrate whether Rab35 is the actual functional tar-
get of miR-720 acting on cell migration of HeLa cells, 
we cotransfected the miR-720 mimic and the miR-720 
insensitive Rab35 vector into HeLa cells, then conducted 
a Transwell® migration assay. Even though there is over-
expression of miR-720, the miR-720 insensitive Rab35 
vector can still restore Rab35 expression and antagonize 
the positive effect of miR-720 on cell migration of HeLa 
cells, finally resulting in inhibition of cell migration, com-
pared with the negative control group transfected with 
the miR-720 mimic and the empty pcDNA3.0-Vector 
(Fig.  6a, b). Thus, we postulate that miR-720 exerts its 
positive function on cell migration of HeLa cells by nega-
tively regulating Rab35, which can suppress cell migra-
tion of HeLa cells.
Molecular mechanism of the miR‑720 effect on cell 
migration of HeLa cells
We next sought to characterize the mechanism of action 
involved in miR-720 induction of HeLa cell migration. 
Epithelial-to-mesenchymal transition (EMT) is an impor-
tant process in morphogenesis and tissue repair, and this 
process is often abnormally activated in cancer cells, which 
will promote their malignant and stem cell characteristics 
and finally accelerate cell migration [49]. To determine if 
EMT was aberrantly changed, we assessed the alterations 
in E-cadherin protein expression, which is a well-estab-
lished marker for epithelial cells, and vimentin, which is 
a marker of mesenchymal cells, in the transfected HeLa 
cells used in the previous functional study [50]. The results 
showed that the forced expression of miR-720 upregu-
lated vimentin and downregulated E-cadherin (Fig.  7a). 
Correspondingly, miR-720 inhibition and overexpres-
sion of Rab35 had the opposite effects on E-cadherin and 
Fig. 4 Rab35 is negatively regulated by miR-720 at the translational level in HeLa cells. Transfection of miR-720 mimics (a) or miR-720 inhibitors (b) 
in HeLa cells did not significantly affect Rab35 mRNA expression levels, as assessed by qRT-PCR analysis. c Representative photographs of Rab35 
protein expression detected by western blotting, and the results of gray intensity analysis using Image J software showed that Rab35 protein levels 
were negatively regulated by miR-720
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vimentin levels; E-cadherin was increased and vimentin 
was decreased (Fig. 7b, c). Collectively, these results sug-
gest that the intrinsic mechanism of miR-720 promotion 
on cell migration by downregulation of Rab35 is essentially 
through the activation of the EMT in HeLa cells.
Discussion
Tumor metastasis remains a major cause of cancer-
related death. Metastasis is comprised of various 
sequential steps, involving cancer cell dissemination, can-
cer cell spreading, and formation of secondary tumors in 
other organs and tissues [51, 52]. The first essential step 
of tumor metastasis and invasion is the change in the 
expression of cell adhesion molecules (CAM), and the 
breakdown and remodeling of the extracellular matrix 
(ECM), resulting in the ability of cancer cells to metasta-
size. Increasing evidence suggests that miRNAs play crit-
ical roles in the regulation of cell migration and invasion, 
Fig. 5 Rab35 has the opposite effect on the migration of HeLa cells, relative to miR-720. a Representative western blot assays show that transfec-
tion with the constructed vector pcDNA3.0-Rab35 results in a high expression level of Rab35. b Representative photographs of wound healing 
assays show that the forced expression of Rab35 decreased cell wound healing ability. The statistical results of cell migration area measured by 
Image J software demonstrate a significant reduction in cell migration caused by overexpression of Rab35. **p < 0.01. c Representative pho-
tographs of Transwell® migration assays and the statistical results show that the forced expression of Rab35 led to a dramatic decrease in cell 
migration. *p < 0.05. d Real-time cell analysis shows that overexpression of Rab35 decreased the cell migration index when compared with the 
corresponding negative control
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as coordinated regulators of ECM remodeling during 
cancer cell migration and invasion [53]. We previously 
reported that miR-720 expression is significantly upreg-
ulated in cervix uteri squamous cell carcinoma tissue 
when compared to normal cervix uteri tissue, indicating 
that miR-720 is closely related to the pathological pro-
cesses of cervical cancer [17]. Some studies have reported 
that miR-720 impedes cell invasion and migration, and 
then inhibits metastasis in breast cancer by directly tar-
geting TWIST1 [16]. In the present study, we showed 
that overexpression of miR-720 leads to a reduction of 
E-cadherin and an increase of vimentin protein levels in 
cervical cancer cell lines, which indicates that miR-720 
can induce EMT in cervical cancer cells and promote cell 
migration. In combination with our previous studies and 
reports from other investigators, we propose that miR-
720 may be an important regulator of cell migration and 
invasion in various cancers, in spite of its functional dif-
ferences that are dependent on distinct cellular microen-
vironments. It was reported that individual miRNA has 
the potential to regulate hundreds of targets [54]. In addi-
tion, a miRNA can not only directly affect the levels of 
target mRNA but also indirectly affect the levels of tar-
get mRNA, in other words, a miRNA can have secondary 
effects or even tertiary effects on its target mRNA [55]. 
Besides, the effects of a miRNA on regulating its targets 
crucially depends on its expression levels and the regula-
tion happened to have a cell-type dependent effect [56–
58]. Therefore, we propose that miR-720 may regulate the 
cell migration processes in various cancer cells by distinct 
molecular mechanism.
Since miR-720 was discovered, it has been widely 
studied as a miRNA. A study showed that miR-720 
could negatively regulate p63 involved in an autoregula-
tory feedback loop, which then contributed to epithelial 
Fig. 6 Restoration of Rab35 expression reverses the promoting effect of miR-720 on cell migration. Representative photographs (a) and statistical 
results (b) of Transwell® assays show that while transfecting miR-720 mimics could lead to a significant increase in cell migration ability compared 
with cells transfected with the microRNA mimic negative control, cotransfecting pcDNA3.0-Rab35 and miR-720 mimics resulted in a dramatic 
decrease in cell migration ability compared with the negative group cotransfected with miR-720 mimics and the pcDNA3.0-Vector. *p < 0.05
Fig. 7 Detection of E-cadherin and vimentin expression by western 
blotting. a HeLa cells transfected with miR-720 mimics show a signifi-
cant increase in vimentin protein expression and a dramatic decrease 
in E-cadherin protein expression. Transfection of miR-720 inhibitors 
(b) or pcDNA3.0-Rab35 (c) had a negative effect (E-cadherin was 
increased and vimentin was decreased), in contrast to transfection of 
miR-720 mimics in HeLa cells
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development processes [59]. The miR-720 could sup-
press cell migration and invasion in breast cancer by 
directly targeting TWIST1 [16]. Furthermore, miR-720 
participates in the control of the stem cell phenotype of 
human dental pulp cells by directly repressing NANOG 
levels [12]. miR-720 is closely related to the patho-
logical processes of various tumors [17]. A more recent 
study showed that overexpression of miR-720 in pri-
mary human CD8+ T cells inhibits the T cell receptor 
(TCR) stimulation-induced proliferation in patients with 
chronic hepatitis B virus (HBV) infection, which sug-
gests that therapies targeting miR-720 may help restore 
impaired immunity in chronic HBV-infected patients 
[60]. However, another study reported that miR-720 
is probably a fragment from a tRNA, rather than an 
miRNA [11]. And other report showed that, as a tRNA-
derived miRNA, miR-720 is one of the four most abun-
dant MCF7 extracellular vesicle miRNAs, suggesting that 
miR-720 may be a new biomarker in breast cancer cells 
[61]. Although there is controversy over whether miR-
720 is a miRNA or a tRNA-derived RNA fragment (tRF), 
functional studies of miR-720 will provide valuable infor-
mation concerning the possible clinical significance of 
this small non-RNA molecule.
As a key regulator of endosomal membrane trafficking 
and the actin cytoskeleton, Rab35 in this study was found 
to be directly regulated by miR-720 at the posttranscrip-
tional level. The small GTPase, Rab35, a member of the 
RAS oncogene family, regulates many essential cellular 
processes, such as recycling from endosomes, exosome 
release, cytokinesis, and actin cytoskeleton organiza-
tion by cycling between a GTP-bound active form and a 
GDP-bound inactive form. Active Rab35 controls recy-
cling pathways to increase cell adhesion and decrease cell 
migration [32]. It is noteworthy that many studies have 
demonstrated a close relationship between Rab35 and 
Arf6, which is also a small GTPase. Both these two small 
GTPases are involved in functionally related cell pro-
cesses, such as cell migration and cytokinesis, endocyto-
sis, actin remodeling, sorting, and recycling of adhesion 
molecules. However, the activities of Rab35 and Arf6 are 
inversely coordinated [24, 27, 62, 63]. To the best of our 
knowledge, this is the first study to provide experimental 
evidences that Rab35 is posttranscriptionally regulated by 
miR-720, which then contributes to the regulation of cell 
migration. Based upon these observations, it is important 
to further validate the functions of the miR-720/Rab35 
axis in tumor metastasis and invasion in animal models 
and clinical tissues in future studies.
Conclusions
Our results show that miR-720 promotes cell migra-
tion in cervical cancer cells by directly targeting 
Rab35. Targeting the miR-720/Rab35 axis is therefore 




HeLa cells and HEK293T cells were obtained from the 
Type Culture Collection of the Chinese Academy of Sci-
ences (Shanghai, China). HeLa cells were cultured in 
Minimum Essential Medium (Gibco/Life Technologies, 
US) and HEK293T cells were incubated in Dulbecco’s 
Modified Eagle’s Medium (Gibco/Life Technologies, 
US). The base medium was supplemented with 10 % fetal 
bovine serum (Gibco/Life Technologies, US) to make the 
complete growth medium, and the cells were incubated 
at 37 °C with 5 % CO2.
Oligonucleotide transfection
The pre-miR-720, miR-720 mimics, inhibitor, and cor-
responding controls were designed and synthesized by 
RiboBio (Guangzhou, China). HEK293T cells were trans-
fected with pre-miR-720 or pre-miR-control at a final 
concentration of 100  nM. HeLa cells were transfected 
with mimics at a final concentration of 100 nM, or trans-
fected with inhibitor at a final concentration of 200 nM 
using Lipofectamine® RNAiMAX reagent (Invitrogen, 
US), following the manufacturer’s instructions. After 
48 h, the cells were harvested for further analysis.
RNA extraction and quantitative real‑time PCR
Total RNA was extracted using TRIzol® Reagent (Life 
Technologies, US) according to the manufacturer’s pro-
tocol. One µg of total RNA was reverse transcribed into 
cDNA with a FastQuant RT Kit (Tiangen Biotech, Bei-
jing, China). Quantitative analyses of miR-720 were 
performed using the Bulge-LoopTM miRNA quantita-
tive RT-PCR primer (RiboBio, Guangzhou, China) and/
or a S-Poly(T) real-time PCR assay of microRNAs assays 
[64], and SYBR Select Master Mix (Life Technologies) on 
an ABI Prism 7500 real-time PCR system (Applied Bio-
systems, Foster City, CA, USA). Quantitative analysis of 
Rab35 was performed using designed qPCR primers (for-
ward, 5′-ACGACCACCTCTTCAAGCTG-3′; reverse, 
5′-CCGGATCTTGAAATCCACTC-3′) and the same 
SYBR Select Master Mix with miR-720 qPCR. PCR was 
performed using 20  µL reaction mixture in triplicate at 
95 °C, for 10 min, followed by 40 cycles of 95 °C for 10 s, 
60  °C for 34  s, and 72  °C for 30  s. U6 snRNA was used 
as an internal control for miRNA analysis, and glyceral-
dehyde 3-phosphate dehydrogenase (GAPDH) mRNA 
was used as an internal control for quantitative analysis 
of mRNA. The results were calculated using the 2−ΔΔCT 
method.
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Microarray analysis
After the experimental HEK293T group was transfected 
with pre-miR-720 and the control HEK293T group 
was transfected with the pre-miR-control for 24  h, the 
HEK293T cells were lysed with TRIzol® reagent (Life 
Technologies, US) and total RNA was extracted according 
to the manufacturer’s protocol. The RNA samples were 
then sent to the Shanghai Biotechnology Corporation 
to perform microarray analysis (Affymetrix GeneChip® 
Human Genome U133 Plus 2.0 Array). Each group sam-
ple set was comprised of three replicates. The Affymetrix 
GeneChip® system was used for hybridization, staining, 
scanning, and imaging of the arrays. Raw data were ana-
lyzed with the Affymetrix GeneChip® Operating Soft-
ware (GCOS1.4) using the manufacturer’s default analysis 
settings and global scaling as the normalization method. 
One-way analysis of variance (ANOVA) was performed 
with GeneSpring 7.31 software (Agilent, Santa Clara, CA, 
USA) to identify genes whose expression changed signifi-
cantly between the pre-miR-720 group and the control.
Luciferase reporter assay
The putative binding sites of the 3′-UTR of the human 
genes for miR-720 targeting were predicted by TargetS-
can Human (http://www.targetscan.org/) computational 
methods.
The partial 3′-UTR fragment (about 250  bp) of these 
potential targets, including predicted binding sites, as 
our previous report [65], were separately cloned into 
the pMIR-REPORT™ miRNA Expression Reporter Vec-
tor (Applied Biosystems) at the Mlu I/Hind III site. The 
primers were designed as Table 1.
The mutant 3′UTR inserts, with an opposite mutation 
in the miRNA seed sequence binding sites, were gener-
ated by overlapping PCR methods [66] using the mutated 
primers, listed as Table 1.
Wild-type and mutation inserts were confirmed by DNA 
sequencing. HEK293T cells were seeded in triplicate at 
a density of 2  ×  105 cells per 24-well plate. The follow-
ing day, cells were transfected with 100  ng wild-type or 
mutated firefly reporter vector, 10 ng of the control vector 
containing Renilla luciferase, and pRL-TK (Promega, US), 
at a final concentration of 50 nM miRNA, or negative con-
trol (NC) precursors, using 1.5  μL Lipofectamine® 2000 
(Invitrogen) per well. Cells were assayed 48 h after trans-
fection with the Dual Luciferase Assay (Promega) accord-
ing to the manufacturer’s instructions. Each experiment 
was repeated at least in triplicate. The efficiency of trans-
fection was normalized using the Renilla luciferase activity.
The pcDNA expression plasmids and plasmid transfection
The coding sequence of Rab35 was ampli-
fied from HeLa cell cDNA by PCR using primers: 
forward, 5′-CGCGGATCCATGGCCCGGGACTACGAC 
CA-3′; reverse, 5′-CCGCTCGAGTTAGCAGCAGCGT 
TTCTTTC-3′. The PCR fragment was inserted using 
BamH I/Xho I into the pcDNA3.0-Vector to generate 
pcDNA3.0-Rab35. The empty pcDNA3.0-Vector was 
used as the negative control. HeLa cells were transfected 
with plasmid using the Lipofectamine® 2000 Transfec-
tion Reagent (Invitrogen) according to the manufac-
turer’s protocol. After 48 h, the cells were harvested for 
further analysis.
Western blot analysis
Total cell extracts (40 µg) were resolved on a 10 % SDS-
PAGE and transferred to nitrocellulose membranes (Mil-
lipore, Germany). Membranes were blocked with 5  % 
skim milk (BioSharp, US) and further incubated with the 
following primary antibodies: Rab35 and the mesenchy-
mal cell marker vimentin (1:2000; San Ying Biotechnol-
ogy, China), the epithelial cell marker E-cadherin (1:200; 
BD Biosciences, US), and GAPDH (1:10,000; Ray Anti-
body Beijing, China). After washing, membranes were 
incubated with a 1:10,000 dilutions of HRP-conjugated 
secondary antibodies (Santa Cruz Biotechnology, Santa 
Cruz, CA, USA). After washing six times with TTBS, 
with each wash lasting 5  min, the membranes were 
incubated with Pierce ECL western blotting substrate 
(Thermo Fisher Scientific, US), and the protein bands 
were visualized by autoradiography and quantified by 
Image J software (NIH, Bethesda, MD, USA).
Cell proliferation assay
For the HeLa cell proliferation assay, cells were tran-
siently transfected for 24 h, and then seeded into 96-well 
plates (6 × 103 cells/well), with each group comprised of 
six replicates. The cell growth was regarded as the initial 
value when the cells had been seeded for 2  h. At indi-
cated times, cells were incubated with 10  μL of 5  mg/
mL 3-4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetra-
zolium bromide (MTT) for 4  h at 37  °C, and then the 
generated crystals were dissolved by dimethyl sulfoxide 
(DMSO). Absorbance was measured at 450  nm using a 
microplate reader (Biotech) every 24 h for four consecu-
tive days.
Wound healing assay
After transfection for 24  h in 6-well plates, cells were 
replated into 12-well plates (2.5 × 105 cells per well), in 
triplicate, for the wound healing assay. When the cells 
reached ~90 % confluency, a 10 µL pipette tip was used 
to scrap across the confluent cell layer, followed by gen-
tle washing three times with phosphate-buffered saline 
(PBS), and then addition of culture medium containing 
2.5  % fetal bovine serum. The scratch was immediately 
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subjected to photography using a light microscope. After 
incubation for 24 h, additional photographs were taken. 
Wound healing ability was determined by measuring the 
scraped area alteration because of cell migration using 
Image J software.
Transwell® assay
After transfection for 24  h, HeLa cells (2.5  ×  104 
cells) were suspended in 300  µL of Minimal Essential 
Medium (MEM) without serum and then reseeded into 
the upper chamber of the Transwell® inserts (8  µm 
pore size; Corning, USA) of a companion 24-well plate 
in pre-warmed containing 10  % FBS. After incubating 
at 37  °C for 24 h, cells on the top surface of the insert 
were removed by gentle wiping with a cotton swab, and 
the cells which migrated to the bottom surface of the 
insert were fixed in 4 % paraformaldehyde for 15 min, 
stained with 0.1  % crystal violet (Sigma-Aldrich, St. 
Louis, MO, USA) for 15  min, rinsed in PBS, and then 
photographed. Cell migration ability was determined 
Table 1 Primers used in this study
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by counting the stained cells in the bottom surface of 
the insert under a light microscope (100×) in eight ran-
domly selected fields. The average number of cells in 
the eight fields was taken as the final result. Each group 
had three replicates and each experiment was repeated 
three times.
Real‑time cell analysis
For real-time cell analysis (RTCA), HeLa cells were 
transiently transfected for 24  h, and 6  ×  104 cells 
were suspended in 100 µL of MEM without serum in 
the upper chamber (ACEA Biosciences; Hangzhou, 
China) according to the basic cell migration assay pro-
tocol of the RTCA xCELLigence system (ACEA Bio-
sciences). Each group had four replicates, and the cell 
migration index was calculated by real-time detection 
for 48 h.
Statistical analysis
Data were expressed as mean  ±  SEM. Student’s t test 
(unpaired, two tailed) was used in the analysis of dif-
ferences between the experimental groups and control 
groups, with p < 0.05 considered statistically significant. 
Statistical analyses were performed using GraphPad 
Prism, version 5.0 software.
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